Home
>
US Stocks
>
Eiger BioPharmaceuticals Inc
Eiger BioPharmaceuticals Inc
EIGR

Eiger BioPharmaceuticals Inc (EIGR)

$6.4817.14%

1D

1W

1M

1Y

3Y

5Y

Key Stats

Open
6.46
Today Low/High
6.41 / 6.55
52 Week Low/High
$7.57 / $13.49
Market Cap
$278.4M

Company Details

Eiger is a commercial-stage biopharmaceutical company focused on the development and commercialization of foundational therapies for Hepatitis Delta Virus (HDV) infection, the most serious form of human viral hepatitis.
Organisation
Eiger BioPharmaceuticals Inc
Headquaters
Palo Alto, California, US
Employees
28
Industry
Health Technology
CEO
David Cory

Discover more

Frequently Asked Questions

What is Eiger BioPharmaceuticals Inc (EIGR) share price today?

Can Indians buy Eiger BioPharmaceuticals Inc (EIGR) shares?

How can I buy Eiger BioPharmaceuticals Inc (EIGR) shares from India?

Can Fractional shares of Eiger BioPharmaceuticals Inc (EIGR) be purchased?

What are the documents required to start investing in Eiger BioPharmaceuticals Inc (EIGR) stocks?

We are a SEBI registered investement advisor